Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin
Small molecule inhibitors, such as imatinib, are effective therapies for tyrosine kinase fusions BCR-ABL–TEL-PDGFβR–mediated human leukemias, but resistance may develop. The unique fusion junctions of these molecules are attractive candidates for molecularly targeted therapeutic intervention using R...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC420507/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15199413/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI20673 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
